Original article: NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study (17 November, 2018)
Morgane Cheminant, Julie Bruneau, Georgia Malamut, David Sibon, Nicolas Guegan, Tom van Gils, Sascha Cording, Amélie Trinquand, Virginie Verkarre, Ludovic Lhermitte, Nicole Brousse, Anne-Sophie Jannot, Sherine Khater, Laurent Frenzel, Richard Delarue, Felipe Suarez, Ambroise Marçais, Chris JJ Mulder, Elizabeth Macintyre, Vahid Asnafi, Laurent Pouyet, Cécile Bonnafous, Florence Lhospice, Thierry Jo Molina, Bertrand Meresse, Christophe Cellier, Nadine Cerf-Bensussan, Olivier Hermine
Commentaries